Abstract P1-12-07: Phase Ib/II single-arm trial evaluating the combination of everolimus, lapatinib and capecitabine for the treatment of patients with HER2-positive metastatic breast cancer with progression in the CNS after trastuzumab (TRIO-US B-09)
Year: 2017
Type: conference-abstract
Source: Cancer Research
Authors: SA Hurvitz, DA Martinez, R Singh, J Taguchi, D Chan, R Dichmann, A Castrellon, J Barstis, E Hu, J Berkowitz, A Mani, B DiCarlo, I Smalberg, E Hobbs, DJ Slamon
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2593078221